Pharma Market-Share Fees In House Health Care Reform Package Less Than Expected
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand drug manufacturers will pay annually increasing fees until 2019, totaling $28 billion over 10 years, after which the figure drops and holds steady.